Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354003 · ClinicalTrials.gov registry record
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
A clinical trial, sponsored by Institute for Neurodegenerative Disorders.
- Completed
- Registry status
- 800
- Enrollment target
NCT00354003 is a clinical trial that has completed, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 800 participants.
The verdict
NCT00354003 has completed, sponsored by Institute for Neurodegenerative Disorders.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and what is the impact of the imaging data information on the management of their symptoms.
Interventions
- BEHAVIORAL A series of questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00354003
The ClinicalTrials.gov registry entry for NCT00354003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institute for Neurodegenerative Disorders, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A series of questionnaires is the first listed.
NCT00354003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00354003 about?
NCT00354003 is a clinical study titled "The Study of the Impact of Disclosing Imaging Study Information to Trial Participants". The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and what is the impact of the imaging data information on the management of their symptoms.
What is the current status of trial NCT00354003?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2006-07. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00354003?
The interventions under investigation include: A series of questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00354003?
This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.